People with PTSD experience high levels of cardiovascular disease and comorbid mental
health problems. Physical activity (PA) is an effective intervention in the general population …

Objective People with posttraumatic stress disorder (PTSD) have a higher mortality than the
general population, mainly due to cardiovascular diseases (CVD). Metabolic syndrome …

Context Although antipsychotic treatment has recently increased, little is known about how
this development has differentially affected the office-based care of adults and young people …

Background: Atypical antipsychotic medications are widely prescribed for the adjunctive
treatment of depression, yet their total risk–benefit profile is not well understood. We thus …

Introduction: New antipsychotics continuously arrive on the market, which thereby influences
the approved and off-label prescribing (OLP) schemes. We aimed to identify the recent …

Context Serotonin reuptake-inhibiting (SRI) antidepressants are the only FDA-approved
pharmacotherapies for the treatment of posttraumatic stress disorder (PTSD). Objective To …

Background: Worldwide, in the absence of standard pediatric prescribing information,
clinicians often use medicines in children in a dosage form or for an indication that has not …

BACKGROUND: Conventional and atypical antipsychotic medications are approved by the
FDA for treatment of schizophrenia and bipolar disorder. Over many decades, the …

The US Department of Veterans Affairs defines post-traumatic stress disorder (PTSD) as “the
development of characteristic and persistent symptoms along with difficulty functioning after …

Dementia represents a global health challenge due to the increase in elderly population
worldwide. In addition to memory loss, dementia often results in severe behavioral and …